4.7 Article

Transcriptomic analysis of mouse limb tendon cells during development

Journal

DEVELOPMENT
Volume 141, Issue 19, Pages 3683-3696

Publisher

COMPANY OF BIOLOGISTS LTD
DOI: 10.1242/dev.108654

Keywords

Transcriptome; Limb; Tendon; Mouse; Scieraxis; TGF-beta; SMAD2/3; ERK

Funding

  1. Fondation pour la Recherche Medicale (FRM)
  2. Centre National de la Recherche Scientifique (CNRS)
  3. Institut National de la Sante et de la Recherche Medicale (INSERM)
  4. Universite Pierre et Marie Curie (UPMC)
  5. Agence Nationale de la Recherche (ANR)
  6. Association Francaise contre les Myopathies (AFM)
  7. FP6 NOE Myores

Ask authors/readers for more resources

The molecular signals driving tendon development are not fully identified. We have undertaken a transcriptome analysis of mouse limb tendon cells that were isolated at different stages of development based on scleraxis ( Scx) expression. Microarray comparisons allowed us to establish a list of genes regulated in tendon cells during mouse limb development. Bioinformatics analysis of the tendon transcriptome showed that the two most strongly modified signalling pathways were TGF-beta and MAPK. TGF-beta/SMAD2/3 gain- and loss-of-function experiments in mouse limb explants and mesenchymal stem cells showed that TGF-beta signalling was sufficient and required via SMAD2/3 to drive mouse mesodermal stem cells towards the tendon lineage ex vivo and in vitro. TGF-beta was also sufficient for tendon gene expression in late limb explants during tendon differentiation. FGF does not have a tenogenic effect and the inhibition of the ERK MAPK signalling pathway was sufficient to activate Scx in mouse limb mesodermal progenitors and mesenchymal stem cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available